| English Alias: |
ethosuximide;C.I. 366;Ethosuximide [USAN:INN:BAN:JAN];2-ethyl-2-methylsuccinimide;3-ethyl-3-methylpyrrolidine-2,5-dione;3-Aethyl-3-methyl-pyrrolidin-2,5-dion;3-ethyl-3-methyl-pyrrolidine-2,5-dione;3-ethyl-3-methylsuccinimide;Emeside;Ethymal;Etosuximida;Petinimid;Petnidan;Suxilep;Suxinutin;Zarondan;Zarontin;Ethosuxide;Ethosuccinimide;Ethosuccimide;Atysmal;Succimitin;Zaraondan;Pyknolepsinum;Peptinimid;Etosuximid;Pentinimid;Zarodan;Thetamid;Simatin;Capitus;Mesentol;Zartalin;Suximal;Succimal;Pemalin;Ronton;Pemal;Suxin;Asamid;Etomal;Aethosuximide;Thilopemal;Piknolepsin;Epileo Petit MAL;Zarondan-Saft;Ethosuximidum;Simatin(E);3-Methyl-3-;3-Methyl-3-ethylsuccinimide;3-Ethyl-3-methyl-pyrrolidine-2,5-dione (ethosuximide);5SEH9X1D1D;WLN: T5VMVTJ D2 D1;2-Methyl-2-ethylsuccinimide;HMS3261L05;Etosuximida [INN-Spanish];Spectrum4_001051;C07505;Tox21_500532;ETHOSUXIMIDE [MART.];KBio1_000218;NSC 64013;NCGC00015418-05;ETHOSUXIMIDE [USP-RS];KBio2_001865;CAS-77-67-8;Spectrum_001385;EINECS 201-048-7;ETHOSUXIMIDE (USP MONOGRAPH);.gamma.-Methyl-.gamma.-ethylsuccinimide;NCGC00015418-09;ETHOSUXIMIDE (USP-RS);BDBM50240424;Ethosuximide (JP17/USP/INN);NSC758192;NCGC00093923-01;4-ethyl-5-hydroxy-4-methyl-3,4-dihydro-2H-pyrrol-2-one;BRD-A99633051-001-04-7;5-21-09-00595 (Beilstein Handbook Reference);alpha-Ethyl-alpha-methylsuccinimide;PM-671;Spectrum3_000944;Piknole.psi.n;NINDS_000218;NCGC00015418-03;2,5-PYRROLIDINEDIONE, 3-ETHYL-3-METHYL-, (+/-)-;DTXCID203019;CHEMBL696;ETHOSUXIMIDE (MART.);Etosuximida (INN-Spanish);W-109273;2, 3-ethyl-3-methyl-;AKOS005261742;NSC-758192;HMS1921L14;Zarontin (TN);HMS1568B11;Aethosuccimidum;PM 671;KBio2_004433;D70258;ETHOSUXIMIDE [INN];CI 366;CHEBI:4887;Ethosuximidum [INN-Latin];ETHOSUXIMIDE (EP MONOGRAPH);Etosuximide;CN-10,395;SDCCGSBI-0050515.P004;gamma-Methyl-gamma-ethyl-succinimide;MFCD00072123;3-Ethyl-3-methylpyrroline-2,5-dione;Spectrum2_001483;(+-)-2-Ethyl-2-methylsuccinimide;NCGC00015418-02;NS00010826;NCGC00093923-04;ETHOSUXIMIDUM [WHO-IP LATIN];3-ethyl-5-hydroxy-3-methyl-3,4-dihydro-2H-pyrrol-2-one;KBioGR_001342;(.+/-.)-Ethosuximide;(2RS)-2-Ethyl-2-methylsuccinimide;zarontin3-Ethyl-3-methyl-pyrrolidine-2,5-dione;EN300-123801;SPBio_001465;HSDB 1119;gamma-ethyl-gamma-methyl-succinimide;NSC64013;CN-10395;SPECTRUM1502196;KBio2_007001;3-Ethyl-3-methyl-2, 5-pyrrolidinedione;Ethosuximide [USAN:USP:INN:BAN:JAN];NCGC00015418-15;EU-0100532;Tox21_110370_1;HMS3885D12;SR-01000075863-1;HY-B1378;UNII-5SEH9X1D1D;SPBio_001950;H 940;NCGC00093923-03;Ethosuccimid;77-67-8;HMS3712B11;DB00593;NCIOpen2_000014;SCHEMBL34212;ETHOSUXIMIDE [ORANGE BOOK];CS-7976;alpha-Methyl-alpha-ethylsuccinimide;KBioSS_001865;BRD-A99633051-001-05-4;Cl 366;SR-01000075863;Succinimide, 2-ethyl-2-methyl-;ETHOSUXIMIDE [WHO-DD];.alpha.-Ethyl-.alpha.-methylsuccinimide;NCGC00016320-01;Prestwick2_000165;3-Ethyl-3-methyl-pyrrolidine-2,5-dione(Ethosuximide);KBio3_002008;Spec... |
